Moderna Inc
MRNAHealthcare|Biotechnology|USA
$48.77
-0.43 (-0.87%)
DCF (FCF)
$77.19
Tangible Book
$21.71
Analyst Ratings
| Firm / Analyst | Rating | Price Target | Date |
|---|---|---|---|
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — |
Analyst Estimates
annual
{
"date": [
"202612",
"202712",
"202812"
],
"revenue_estimate": [
2069.81,
2415.43,
2903.52
],
"ebit_estimate": [
-2842.2,
-2070.9,
-1289.63
],
"ebitda_estimate": [
-2649.29,
-1718.57,
-972.93
],
"net_income_estimate": [
-2714.03,
-1929.89,
-1296.25
],
"per_share_eps_estimate": [
-6.99,
-4.96,
-3.38
],
"eps_nri_estimate": [
-6.89,
-4.85,
-3.21
],
"dividend_estimate": [
null,
null,
null
],
"book_value_per_share_estimate": [
16.48,
12.52,
9.35
],
"pretax_income_estimate": [
-2602.49,
-1885.57,
-1229.36
],
"operating_cash_flow_per_share_estimate": [
-5.41,
-4.17,
-2.85
],
"roa_estimate": [
-30.4,
-13.53,
-5.7
],
"roe_estimate": [
-37.78,
-30.99,
-23.75
],
"gross_margin_estimate": [
56.67,
65.98,
70.76
],
"operating_cash_flow_estimate": [
-2122.29,
-1634.64,
-1118.49
],
"pettm_estimate": [
0,
0,
0
],
"long_term_growth_rate_mean": 24.37,
"long_term_revenue_growth_rate_mean": "14.94",
"future_per_share_eps_estimate_growth": 23.21,
"future_eps_nri_estimate_growth": 24.37,
"future_revenue_estimate_growth": 14.94,
"future_ebit_estimate_growth": 22.87,
"future_ebitda_estimate_growth": 28.22,
"future_dividend_estimate_growth": null,
"future_net_income_estimate_growth": 23.47,
"future_pretax_income_estimate_growth": 24.1,
"future_book_value_per_share_estimate_growth": -24.69,
"future_roa_estimate_growth": 37.91,
"future_roe_estimate_growth": null,
"future_gross_margin_estimate_growth": 9.6,
"future_operating_cash_flow_per_share_estimate_growth": 16.73
}
quarterly
{
"date": [
"202603",
"202606",
"202609",
"202612",
"202703",
"202706",
"202709",
"202712"
],
"revenue_estimate": [
227.64,
125.17,
968.27,
721.01,
197.45,
162.25,
1273.3,
1097.13
],
"ebit_estimate": [
-862.73,
-877.14,
-413.9,
-611.62,
-832.75,
-775.16,
99.21,
160.15
],
"ebitda_estimate": [
-1042.72,
-1067.95,
-562.9,
-883.3,
null,
null,
null,
null
],
"net_income_estimate": [
-789.31,
-825.47,
-364.48,
-578.48,
-797.8,
-834.6,
106.06,
-214.67
],
"per_share_eps_estimate": [
-2.09,
-2.07,
-0.89,
-1.39,
-1.81,
-1.9,
-0.45,
-0.77
],
"eps_nri_estimate": [
-2.08,
-2.1,
-0.91,
-1.4,
-2.01,
-2.12,
-0.07,
-0.65
],
"dividend_estimate": [
null,
null,
null,
null,
null,
null,
null,
null
],
"book_value_per_share_estimate": [
null,
null,
null,
null,
null,
null,
null,
null
],
"pretax_income_estimate": [
-825.56,
-831.23,
-365.57,
-547.45,
-1092.9,
-690.85,
185.49,
254.48
],
"operating_cash_flow_per_share_estimate": [
-0.8,
-0.99,
-0.82,
-1.62,
null,
null,
null,
null
],
"roa_estimate": [
-6.3,
-7.5,
-4.9,
-7.3,
null,
null,
null,
null
],
"roe_estimate": [
-9,
-11.1,
-7.3,
-11.2,
null,
null,
null,
null
],
"gross_margin_estimate": [
51.25,
51.74,
60.41,
56.13,
40.06,
44.59,
67.01,
62.3
],
"operating_cash_flow_estimate": [
-314.89,
-388.08,
-320.15,
-633.75,
null,
null,
null,
null
],
"pettm_estimate": [
0,
0,
0,
0,
0,
null,
null,
null
],
"long_term_growth_rate_mean": 24.37,
"long_term_revenue_growth_rate_mean": "14.94",
"future_per_share_eps_estimate_growth": 23.21,
"future_eps_nri_estimate_growth": 24.37,
"future_revenue_estimate_growth": 14.94,
"future_ebit_estimate_growth": 22.87,
"future_ebitda_estimate_growth": 28.22,
"future_dividend_estimate_growth": null,
"future_net_income_estimate_growth": 23.47,
"future_pretax_income_estimate_growth": 24.1,
"future_book_value_per_share_estimate_growth": -24.69,
"future_roa_estimate_growth": 37.91,
"future_roe_estimate_growth": null,
"future_gross_margin_estimate_growth": 9.6,
"future_operating_cash_flow_per_share_estimate_growth": 16.73
}